X
GO
CARICOM Member State Engagement

CARICOM Ministers of Health issued a decision to implement the CRS in 2014 and have reaffirmed that decision in subsequent years.

The CRS has also begun to pursue Memorandums of Understanding with individual states to further cement engagement. The below graphic shows the present state of this engagement.

Note that the OECS Pharmaceutical Procurement Service signed an MOU so those participating countries are coloured in.


CARPHA/CRS Recommended Medicines

CARPHA/CRS recommends the medicines listed in this document to CARICOM member states for granting marketing authorization/import permit.

VigiCarib (Pharmacovigilance and Post Market Surveillance)

VigiCarib is a voluntary regional system for CARICOM states to report medicines related adverse events (adverse drug reactions (ADRs)) and substandard and falsified (SF) products. Medicines safety and monitoring systems are often limited in the individual small states of CARICOM, and the rationale for a regional approach is that with pooling of resources, sharing of information, and coordination of activities, there will be efficiencies of scale that can lead to stronger systems overall.